BUSINESS
Sun Pharma, Lupin, Alkem recall products from US market
Sun Pharma is recalling 54,960 bottles of Mesalamine Extended-Release Capsules, an anti-inflammatory medicine used to treat a type of bowel disease known as ulcerative colitis
BUSINESS
Inhaler sales hit new high in January as India struggles to breathe
A product from the acute segment is among the leaders of the pack, which is usually dominated by therapies for chronic conditions
HEALTH-AND-FITNESS
Can your cotton candy cause cancer? Why Tamil Nadu has banned the sweet
Samples collected from beaches in Chennai revealed the presence of a popular textile dye named Rhodamine-B
BUSINESS
Eris Lifesciences acquires 51% in Swiss Parenterals for Rs 637 crore
This deal also marks the entry of Eris into the RoW Export Markets.
BUSINESS
Zydus Life Q3 net surges 26% YoY, board approves buyback worth Rs 600 crore
Zydus Life Q3 results: The Board approved buy-back of upto Rs. 6000 million at Rs. 1005 per equity share (25% premium to closing share price of 8th February, 2024).
TRENDS
Riding on Novo Nordisk’s semaglutide, India’s weight-loss market triples in size in 2 years
Semgalutide has almost 66 percent of the market share in the anti-obesity segment.
BUSINESS
Alembic Pharma gears up for multiple product launches in coming quarters
The Vadodra-based pharma manufacturer does not foresee additional capital expenditure for these initiatives but is shifting its strategic focus on new generation drugs over legacy products
BUSINESS
Aster DM Healthcare to add 1,500 beds in 3 years, lines up Rs 850 crore investments
The company is exploring opportunities in Maharashtra, Tamil Nadu, and Uttar Pradesh, with plans to enter markets where it can secure a position among the top three healthcare companies.
BUSINESS
Budget allocates Rs 90,658 crore to health ministry, reflecting a 12.5% increase
The AYUSH Ministry has been allocated Rs 3712.49 crore for FY 25 which is 23 percent higher than the previous year
BUSINESS
Health sector to benefit from focus on public healthcare
Vaccinating girls against cervical cancer, the launch of more medical colleges, and improved mother-and-child care plans, among others, are seen as big positives for healthcare companies.
BUSINESS
FM Sitharaman announces govt initiative to promote cervical cancer vaccination among girls aged 9 to 14
India has a population of 511.4 million women aged 15 years and older who are at risk of developing cervical cancer. Cervical cancer ranks as the second most frequent cancer among women in India.
BUSINESS
Healthcare needs a strong dose of support from Union Budget, say experts
Experts call for increased allocation for rural and last-mile connectivity for improving healthcare facilities in India for Budget 2024
TRENDS
Explained: What's Novartis' new anti-cholesterol jab all about
Novartis India is poised to launch its groundbreaking twice-a-year cholesterol jab, Inclisiran, in January.
INDIA
India mandates justification for antimicrobial prescriptions in Medical Colleges
4.6 percent of patients were found to have taken four or more types of antibiotics according to a recent survey by the National Centre for Disease Control (NCDC)
BUSINESS
Budget 2024: Healthcare sector seeks focus on R&D, tax reforms and improving access
Budget 2024: Pharma manufacturers feel that the budget must focus on life sciences innovation and speed up research if the industry is to achieve its goal of $ 120-130 billion in market size by 2030
TRENDS
Wockhardt has more antibiotics in the pipeline: Dr Habil Khorakiwala
Wockhardt could be more of a research company in five years than what it is today.
BUSINESS
What do stricter GMP guidelines mean for Indian pharma companies?
The revised rules are expected to benefit companies focused on the domestic market. However, small companies may come under pressure because they may need a substantial capex to conform
BUSINESS
India a main force in Asian Healthcare deal activity: Bain & Co
According to the report, India hosted 22 in 2023 for a deal value of $4.6 billion. In 2022, the deal value was $4.7 billion.
TRENDS
Drug pricing watchdog fixes retail rates for 19 formulations, including cancer pills
Cancer medication Trastuzumab manufactured by Hetero Biopharma Limited and Mankind Pharma Limited will have a ceiling price of Rs 15817.49 per vial.
INDIA
Glenmark launches biosimilar of anti-diabetic drug, vows to cut down therapy cost by 70%
Priced at around Rs 100 for a standard dose of 1.2 mg (per day), this will lower the cost of therapy by approximately 70 percent
BUSINESS
India’s digital healthcare companies have less than 9 months of cash left: report
The sector is grappling with a cash crunch due to a lack of private capital funding and a high rate of spending, Tata Capital said in a recent report.
BUSINESS
US FDA releases detailed observations at Torrent's Chhatral unit; shares trade high
This was a Pre-Approval inspection conducted from 5 December to 11 December 2023.
BUSINESS
Indira IVF plans aggressive expansion into child and maternal healthcare
India’s healthcare delivery market is expected to grow at 15-17 percent compounded annual growth rate (CAGR) and reach Rs 7.67 trillion in the financial year 2025
BUSINESS
A year of hits and misses for the Indian pharma sector
Even as pharma exports grew in terms of volumes and value, the cloud of inadequate hygiene and safety in some pharma companies continued to hang over the industry, forcing the government to put in place more stringent inspections and processes.
